Bioserve Biotechnologies India Pvt. Ltd.
Mandar Kulkarni - Chief Technology Officer
My journey in healthcare, starting with a PhD in molecular cell biology focusing on cancer, led to a career shift during my postdoctoral fellowship at Yale. I became the first employee of a molecular diagnostics startup, transitioning from molecular carcinogenesis to clinical microbiology. Over three years, I developed clinical assays for antibiotic resistance and managed a genomics division. These experiences prepared me for Cancer Genetics Inc.'s goals in India, focusing on next-generation sequencing (NGS) for personalized cancer diagnostics. NGS technology enhanced our ability to analyze genetic aberrations comprehensively, solidifying our role in personalized cancer care.
26 - 27 Apr 2024
Sheraton San Diego Hotel & Marina 1380 Harbor Island Drive San Diego, California 92101
29 Apr 2024
.jpg "AI Medical Service Inc. Secures Initial Pharmaceutical Registration for Gastric AI-driven Endoscopic Diagnosis Support System from Brazil's ANVISA")
.jpg "Medtronic Innovates with Live Stream Technology and AI Analysis for Laparoscopic and Robotic-Assisted Procedures")
.jpg)
